0001852950-22-000003.txt : 20221122 0001852950-22-000003.hdr.sgml : 20221122 20221122162017 ACCESSION NUMBER: 0001852950-22-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221122 DATE AS OF CHANGE: 20221122 EFFECTIVENESS DATE: 20221122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enlaza Therapeutics, Inc. CENTRAL INDEX KEY: 0001852950 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-393460 FILM NUMBER: 221410646 BUSINESS ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, STE. 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-348-2180 MAIL ADDRESS: STREET 1: 11099 NORTH TORREY PINES ROAD, STE. 290 CITY: LA JOLLA STATE: CA ZIP: 92037 D/A 1 primary_doc.xml X0708 D/A LIVE 0001852950 Enlaza Therapeutics, Inc. 11099 NORTH TORREY PINES ROAD, STE. 290 LA JOLLA CA CALIFORNIA 92037 858-348-2180 DELAWARE None None Corporation true 2020 Sergio Duron c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Sanford Madigan c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 290 La Jolla CA CALIFORNIA 92037 Executive Officer Tighe Reardon c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 290 La Jolla CA CALIFORNIA 92037 Executive Officer Jay Lichter c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 290 La Jolla CA CALIFORNIA 92037 Director Shelley Chu c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 290 La Jolla CA CALIFORNIA 92037 Director James Topper c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 290 La Jolla CA CALIFORNIA 92037 Director Marcos Milla c/o Enlaza Therapeutics, Inc. 11099 North Torrey Pines Road, Ste 290 La Jolla CA CALIFORNIA 92037 Director Pharmaceuticals Decline to Disclose 06b true 0001852950-21-000001 2021-03-12 true true false 0 61330607 35299237 26031370 Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness. false 10 0 0 0 false Enlaza Therapeutics, Inc. /s/ Sergio Duron Sergio Duron Chief Executive Officer 2022-11-22